Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4790
Gene Symbol: NFKB1
NFKB1
0.010 Biomarker disease BEFREE Therefore, the current study investigated P50 suppression in young adolescents (12-17 years old) with either EOP (N = 55) or ADHD (N = 28) and age and gender matched healthy controls (HC) (N = 71). 31649298 2020
Entrez Id: 1896
Gene Symbol: EDA
EDA
0.010 Biomarker disease BEFREE ADHD was associated with significantly elevated parasympathetic (i.e., augmented RSA) and sympathetic (as indexed by EDA) reactivity. 31808007 2020
Entrez Id: 8874
Gene Symbol: ARHGEF7
ARHGEF7
0.010 Biomarker disease BEFREE Therefore, the current study investigated P50 suppression in young adolescents (12-17 years old) with either EOP (N = 55) or ADHD (N = 28) and age and gender matched healthy controls (HC) (N = 71). 31649298 2020
Entrez Id: 115482723
Gene Symbol: H3P40
H3P40
0.010 Biomarker disease BEFREE Therefore, the current study investigated P50 suppression in young adolescents (12-17 years old) with either EOP (N = 55) or ADHD (N = 28) and age and gender matched healthy controls (HC) (N = 71). 31649298 2020
Entrez Id: 836
Gene Symbol: CASP3
CASP3
0.010 Biomarker disease BEFREE Herein, we studied the phosphorylated Akt (pAkt) and caspase-3, the key regulators of neuronal cell survival/death, as the probable downstream targets of MK-801 often used to engender ADHD-like condition. 31756355 2020
Entrez Id: 183
Gene Symbol: AGT
AGT
0.010 Biomarker disease BEFREE Angiotensin II modulates amphetamine-induced glial and brain vascular responses, and attention deficit via angiotensin type 1 receptor: Evidence from brain regional sensitivity to amphetamine. 31646669 2020
Entrez Id: 958
Gene Symbol: CD40
CD40
0.010 Biomarker disease BEFREE Therefore, the current study investigated P50 suppression in young adolescents (12-17 years old) with either EOP (N = 55) or ADHD (N = 28) and age and gender matched healthy controls (HC) (N = 71). 31649298 2020
Entrez Id: 51008
Gene Symbol: ASCC1
ASCC1
0.010 Biomarker disease BEFREE Therefore, the current study investigated P50 suppression in young adolescents (12-17 years old) with either EOP (N = 55) or ADHD (N = 28) and age and gender matched healthy controls (HC) (N = 71). 31649298 2020
Entrez Id: 5624
Gene Symbol: PROC
PROC
0.010 Biomarker disease BEFREE Changes in ADHD severity, impairment, parenting factors, and neuropsychological functioning over time as a function of treatment condition were assessed using the PROC MIXED procedure in SAS. 31834588 2020
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
0.010 GeneticVariation disease BEFREE To our best knowledge, this is the first statistical significant association between FAAH rs2295633 genotype and ADHD disorder. 31377429 2020
Entrez Id: 5741
Gene Symbol: PTH
PTH
0.010 AlteredExpression disease BEFREE The mean serum 25OHD concentration (16.57 ± 9.09 ng/mL) was found to be significantly lower in ADHD children with more parathyroid hormone (PTH) levels as compared to controls (22.01 ± 12.67ng/mL). 31514566 2020
Entrez Id: 10810
Gene Symbol: WASF3
WASF3
0.010 GeneticVariation disease BEFREE Adolescent/young adult (AYA) ADHD and ODD severity measured at Wave 1, AYA delinquency measured at Wave 2, and school disciplinary actions combined from Waves 1 and 2 were explored as mediators of the association between childhood ADHD and lifetime maternal CS at Wave 3 using path analysis. 31750692 2020
Entrez Id: 5345
Gene Symbol: SERPINF2
SERPINF2
0.010 GeneticVariation disease BEFREE 2015), two for ADHD (AAP 2011a, b; SIGN 2009a, b, c, d, e), and two for aggression (Knapp et al.2012; Scotto Rosato et al.2012a, b) met minimum quality criteria. 30927153 2019
Entrez Id: 23191
Gene Symbol: CYFIP1
CYFIP1
0.010 GeneticVariation disease BEFREE We identified nominally significant (alpha < 0.05) GxE interactions of acute life events with CYFIP1-rs3693 on ADHD diagnosis (p = 0.004; fdr = 0.096) but no significant association of any single marker. 31707462 2019
Entrez Id: 10017
Gene Symbol: BCL2L10
BCL2L10
0.010 Biomarker disease BEFREE Results were compared with ADHD diagnosis obtained from a stepped approach: first, a structured interview (Diagnostic Interview for ADHD in adults 2.0.; DIVA) was applied; second, probable ADHD diagnoses had to be confirmed by two expert clinicians. 30583265 2019
Entrez Id: 407037
Gene Symbol: MIR320A
MIR320A
0.010 Biomarker disease BEFREE Results showed that six miRNAs (miR-652-3p, miR-942-5p, let-7b-5p, miR-181a-5p, miR-320a, and miR-148b-3p) and 560 genes were significantly DE in children with ADHD compared to TD subjects. 31652596 2019
Entrez Id: 9048
Gene Symbol: ARTN
ARTN
0.010 GeneticVariation disease BEFREE ADHD risk alleles correlated with increased expression (and decreased methylation) of ARTN and PIDD1 and with a decreased expression (and increased methylation) of C2orf82. 31582733 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.010 Biomarker disease BEFREE Baseline CSF biomarkers (amyloid beta (Aβ) 1-42, Aβ42/40, Tau, and pTau181), interpreted according to the ES, were used to estimate time to progression from the MCI stage of AD to ADD, conditional on age, gender, APOE ε4 genotype, and Mini Mental State Examination score in 144 MCI subjects, using the Extended Cox Model; the subjects were followed-up until they developed dementia or until they had been cognitively stable for at least 2 years. 30611311 2019
Entrez Id: 64116
Gene Symbol: SLC39A8
SLC39A8
0.010 GeneticVariation disease BEFREE Here we investigate if sex and polymorphisms in Mn transporter genes SLC30A10 and SLC39A8 influence the association between Mn exposure and ADHD-related behavioral problems in children. 31233999 2019
Entrez Id: 2891
Gene Symbol: GRIA2
GRIA2
0.010 Biomarker disease BEFREE We recorded AMPAR mediated synaptic transmission at hippocampal excitatory synapses and quantified immunogold labelling density of AMPAR subunits GluA1 and GluA2/3 in a rat model for ADHD; the spontaneously hypertensive rat (SHR). 30552946 2019
Entrez Id: 8704
Gene Symbol: B4GALT2
B4GALT2
0.010 GeneticVariation disease BEFREE Genes known to be associated with ADHD (e.g., <i>B4GALT2, SLC6A9 TLE1, ANK3, TRIO, TAF1,</i> and <i>SYNE1</i>) were confirmed to be significantly DE in our study. 31652596 2019
Entrez Id: 2247
Gene Symbol: FGF2
FGF2
0.010 AlteredExpression disease BEFREE <b>Conclusion:</b> To our knowledge, the present study is the first to examine serum VEGF and FGF-2 levels in children with ADHD. 31170860 2019
Entrez Id: 6314
Gene Symbol: ATXN7
ATXN7
0.010 Biomarker disease BEFREE These findings suggest that Atxn7 plays a role in the pathophysiology of ADHD, and that the Atxn7 OE mice can be used as an animal model of the hyperactive-impulsive phenotype of this disorder. 30125623 2019
Entrez Id: 1376
Gene Symbol: CPT2
CPT2
0.010 Biomarker disease BEFREE The diagnostic clinical utility of Conners' CPT II and QbTest was analysed using receiver operator characteristics (ROC) and post-test probability in 80 children with and 38 without ADHD. 30452083 2019
Entrez Id: 56925
Gene Symbol: LXN
LXN
0.010 Biomarker disease BEFREE The ECI-4 HI and IA subscales showed acceptable accuracy in identifying ADHD in boys and girls (areas under the curve ranged from .67 to .85). 30958025 2019